Its a complete joke, nasdaq listing was not needed and did not help, look at biotechs like CUV on the ASX, that made it huge staying right here on the ASX, or even directly comparable BOT that is a biotech using cannabinoids, went from 5.5 cents to 21 cents staying here on ASX. Yet IHL with access to all those huge hedge funds in USA on nasdaq dropped over 70% and at multi year lows.
If the company is good investors will come no matter where the company is listed.
I just think management looking after themselves here, look at Mr Joel Latham salary last year:
View attachment 5911582check out that total of over $3 million. How long you think until we need another cap raise just to pay Joel his salary for his "performance" ?!